Previous 10 | Next 10 |
Clearmind Medicine Inc. (CMND) is expected to report for Q1 2024
2024-05-08 08:36:23 ET More on pre-market losers & stocks. Siyata Mobile Inc. (SYTA) Q4 2023 Earnings Call Transcript Integral Ad Science Holding Corp. (IAS) Q4 2023 Earnings Call Transcript IPO Roundup: Rubrik, Marex Group, Loar Holdings, and more Integr...
2024-05-07 11:56:30 ET DENVER, Colo., May 07, 2024 ( 247marketnews.com )- Kraig Biocraft Laboratories (OTCQB: KBLB ), Hims & Hers Health, Inc. (NYSE: HIMS ), Nuwellis (Nasdaq: NUWE ), Clearmind Medicine Inc. (Nasdaq: CMND ), and reAlpha Tech (Na...
2024-05-07 10:01:47 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...
A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...
2024-05-07 08:37:20 ET More on premarket gainers & stock Bioventus Inc. 2023 Q4 - Results - Earnings Call Presentation Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript SciSparc to acquire vehicle importer AutoMax SciSparc gains on grant of patent for...
2024-05-07 08:31:48 ET More on Clearmind Medicine Inc. Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation SciSparc gains as Clearmind partnership yields 3 new international patent applications Financial information for Clearmind Medici...
Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated ...
Vancouver, Canada, April 30, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWYO) (" Clearmind " or the “ Company ”), a clinical- stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
2024-04-17 08:59:42 ET More on Clearmind Medicine Inc. Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation SciSparc gains as Clearmind partnership yields 3 new international patent applications Financial information for Clearmind Medici...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...